Ana Maria Burguiere

Title: Ana Maria Burguiere: Innovator in SARS Research

Introduction

Ana Maria Burguiere is a distinguished inventor based in Clamart, France. She has made significant contributions to the field of virology, particularly in research related to the severe acute respiratory syndrome (SARS)-associated coronavirus. With two patents to her name, she has established herself as an influential figure in scientific innovation.

Latest Patents

Among Ana Maria Burguiere's latest patents is a groundbreaking invention concerning a novel strain of SARS-associated coronavirus, stemming from a sample collected in Hanoi, Vietnam. This invention, identified by reference number 031589, encompasses nucleic acid molecules derived from the genome of the coronavirus, as well as the proteins and peptides encoded by these molecules. Notably, her invention highlights protein N and its potential applications, including the development of diagnostic reagents and vaccines.

Career Highlights

Ana Maria has worked with prestigious institutions, including the Centre National de la Recherche Scientifique (CNRS) and Université Paris 7. Her research contributions have been pivotal in understanding and combating viral infections, placing her among noteworthy scientific leaders in her field.

Collaborations

Throughout her career, Ana Maria Burguiere has collaborated with esteemed colleagues such as Sylvie Van Der Werf and Nicolas Escriou. These collaborations have fostered research opportunities and propelled advancements in the study of coronaviruses, further enhancing the impact of her work.

Conclusion

Ana Maria Burguiere stands out as a prominent inventor with a focus on innovative solutions to combat SARS-related diseases. Her patents represent vital advancements in virology, showcasing her dedication and expertise in the realm of medical research. Her career serves as an inspiring example of how innovative thinking and collaboration can lead to significant scientific breakthroughs.